Table 3.
The frequencies of Class I HLA-associated drug hypersensitivity and related drug adverse reactions.
| HLA Pharmacogenetics Marker | Allele Frequency (%) | Drug | ADR Type | |||||
|---|---|---|---|---|---|---|---|---|
| Thai Population (n = 470) [25] | African Americans (n = 252) [26] | North American (n = 187) [26] | Caucasians (n = 265) [26] | Hispanics (n = 234) [26] | Asians (n = 358) [26] | |||
| HLA-A*01:01 | 2.23 | 5.56 | 7.49 | 15.09 | 5.98 | 1.53 | Phenobarbital | SCARs, MPE [32] |
| HLA-A*24:02 | 11.49 | 2.78 | 22.73 | 6.6 | 12.18 | 18.94 | Carbamazepine | SJS/TEN [33] |
| Phenytoin | SJS/TEN [33] | |||||||
| Lamotrigine | SJS/TEN, MPE [33] | |||||||
| HLA-A*30:02 | 0 | 4.96 | 1.87 | 0.57 | 3.42 | 0.14 | Amoxicillin-Clavulanate | DILI [34] |
| HLA-A*31:01 | 0.85 | 0.79 | 7.75 | 3.21 | 4.91 | 3.06 | Carbamazepine | CADRs, SJS/TEN, DRESS, MPE [35,69,70] |
| 0.85 | 0.79 | 7.75 | 3.21 | 4.91 | 3.06 | Lamotrigine | SCARs [36] | |
| HLA-A*33:03 | 11.17 | 3.97 | 0.53 | 0.57 | 1.07 | 11.7 | Allopurinol | SJS/TEN [71,72] |
| Ticlopidine | DILI [73] | |||||||
| HLA-A*68:01 | 0.96 | 2.58 | 5.62 | 3.02 | 2.56 | 0.28 | Lamotrigine | SCARs [37] |
| HLA-B*13:01 | 5.96 | 0 | 0 | 0 | 0 | 3.34 | Phenytoin | SCARs [38] |
| Phenobarbital | DRESS [32] | |||||||
| Dapsone | DRESS [39] | |||||||
| Salazosulfa-pyridine | DRESS [40] | |||||||
| HLA-B*15:02 | 7.66 | 0.2 | 0 | 0 | 0 | 4.87 | Carbamazepine | SJS/TEN [35,69,70] |
| Oxcarbazepine | MPE, SJS [35] | |||||||
| Phenytoin | SJS/TEN [35] | |||||||
| Cotrimoxazole | SJS/TEN [74] | |||||||
| HLA-B*15:11 | 0.21 | 0 | 0 | 0 | 0 | 0.28 | Carbamazepine | SJS/TEN [35,69] |
| HLA-B*15:13 | 0.96 | 0 | 0 | 0 | 0 | 0.28 | Phenytoin | SJS/TEN, DRESS [33,75,76] |
| HLA-B*35:05 | 1.91 | 0 | 0 | 0.38 | 0.85 | 0.14 | Nevirapine | SJS/TEN, DRESS [69,77] |
| HLA-B*38:01 | 0 | 0.4 | 1.07 | 2.45 | 1.71 | 0.42 | Co-trimoxazole | SJS/TEN [78] |
| HLA-B*38:02 | 4.26 | 0 | 0 | 0.19 | 0 | 6.55 | Oxcarbazepine | MPE [79] |
| Co-trimoxazole | SJS/TEN [78] | |||||||
| HLA-B*51:01 | 4.26 | 1.2 | 11.23 | 5.66 | 6.2 | 6.69 | Phenobarbital | SJS/TEN [32] |
| HLA-B*56:02 | 0.11 | 0 | 0 | 0 | 0 | 0.28 | Phenytoin | DRESS [38] |
| HLA-B*57:01 | 1.17 | 2.39 | 2.14 | 4.15 | 1.92 | 0.97 | Abacavir | AHS [35,69,80] |
| Flucloxacillin | DILI [81] | |||||||
| HLA-B*58:01 | 6.38 | 6.37 | 0.8 | 1.13 | 1.07 | 7.38 | Allopurinol | CADRs, SCARs, MPE, SJS/TEN, DRESS [35,69,71,82] |
| HLA-B*59:01 | 0 | 0 | 0 | 0 | 0 | 0.56 | Methazolamide | SJS/TEN [83] |
| HLA-C*03:02 | 7.77 | 2.78 | 0.27 | 0.38 | 1.07 | 7.66 | Allopurinol | SJS/TEN [71,72] |
| HLA-C*06:02 | 4.26 | 11.31 | 5.62 | 8.68 | 6.84 | 3.62 | Co-trimoxazole | SJS/TEN [74] |
| HLA-C*08:01 | 10.32 | 0.2 | 2.41 | 0 | 1.71 | 11.28 | Carbamazepine | SJS/TEN [33] |
| Phenytoin | SJS/TEN [84] | |||||||
| Allopurinol | SJS/TEN [84] | |||||||
| Co-trimoxazole | SJS/TEN [74] | |||||||